HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.

Abstract
This study aimed to evaluate the effect of FR128998, (1s,6s)-1-benzyl-10-(3-pyridyl-methyl)-7-thia-10-azaspiro [5,6]-dodecan-11-one 7,7-dioxide hydrochloride, a novel platelet activating factor (PAF) receptor antagonist, on endotoxin lipopolysaccharide-induced disseminated intravascular coagulation in rats. Experimental disseminated intravascular coagulation was induced by an infusion of lipopolysaccharide at 0.25 mg/kg/h for 4 h. Simultaneous infusion of FR128998 (0.25 and 1.0 mg/kg/h) with lipopolysaccharide dose dependently inhibited thrombocytopenia, but not leukopenia. The changes in coagulation parameters of disseminated intravascular coagulation, i.e., prolongation of activated partial thromboplastin time and elevated levels of fibrinogen/fibrin degradation products, were also prevented by the treatment with FR128998. In addition, FR128998 attenuated the increase in serum tumor necrosis factor (TNF) which appeared during the initial stage of disseminated intravascular coagulation. FR128998 (10 microM) also inhibited the TNF production by peripheral blood leukocytes or alveolar macrophages stimulated by lipopolysaccharide in vitro. Furthermore, TNF production induced by PAF itself in vitro was also inhibited in the presence of FR128998. These data indicate that PAF plays a pivotal role in the development of disseminated intravascular coagulation via TNF production.
AuthorsY Yokota, N Inamura, M Asano, Y Yamamoto, K Nakahara, Y Notsu, T Ono, M Watanabe
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 258 Issue 3 Pg. 239-46 (Jun 13 1994) ISSN: 0014-2999 [Print] Netherlands
PMID8088357 (Publication Type: Journal Article)
Chemical References
  • Endotoxins
  • FR 128998
  • Lipopolysaccharides
  • Platelet Activating Factor
  • Platelet Membrane Glycoproteins
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Spiro Compounds
  • Tumor Necrosis Factor-alpha
  • platelet activating factor receptor
Topics
  • Animals
  • Blood Coagulation (drug effects)
  • Cells, Cultured
  • Disseminated Intravascular Coagulation (blood, etiology)
  • Endotoxins (toxicity)
  • Humans
  • Leukocyte Count (drug effects)
  • Leukocytes (drug effects, metabolism)
  • Lipopolysaccharides
  • Macrophages, Alveolar (drug effects, metabolism)
  • Male
  • Platelet Activating Factor (pharmacology)
  • Platelet Count (drug effects)
  • Platelet Membrane Glycoproteins (antagonists & inhibitors)
  • Rabbits
  • Rats
  • Rats, Wistar
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Spiro Compounds (administration & dosage, pharmacology, therapeutic use)
  • Tumor Necrosis Factor-alpha (biosynthesis, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: